How We Can Help You
Rhabdomyosarcoma is a rare cancer involving the area around the eye. It is most often found in children and is the most common cancer in children affecting the eye area. Treatment has improved considerably over the last few decades.
Treatment at an academic medical center which manages a high volume of rhabdomyosarcomas is important for the best outcomes.
Stanford is a global referral center for rhabdomyosarcomas and is at the forefront of developing new, minimally invasive procedures that treat them.
WHAT WE OFFER YOU FOR ORBITAL RHABDOMYOSARCOMA
- Globally-recognized expertise in the diagnosis and management of orbital rhabdomyosarcoma.
- Team-based treatment planning that brings together specialists from neurosurgery, head and neck surgery, neuroradiology, neuropathology, neuro-ophthalmology, oculoplastic surgery, and more.
- Access to advanced imaging and surgery techniques.
- An active clinical research program dedicated to broadening options for the diagnosis and treatment of orbital rhabdomyosarcomas.
- Assistance from our International Medical Services team to plan your travel and accommodations.
Treatment Options for Orbital Rhabdomyosarcoma
The standard treatment for orbital rhabdomyosarcoma is surgery with the goal of removing all or as much of the tumor as possible, followed by chemotherapy, and radiation therapy. There is a potential for complication from the chemotherapy and that should be monitored closely by ophthalmologists.
Clinical Trials for Orbital Rhabdomyosarcomas
Clinical trials evaluate new approaches, devices, or medications in the treatment of orbital rhabdomyosarcomas. Ask your doctor or clinical trials coordinator about available trials that may be additional options for your care.
To learn more about the clinical trials we offer, contact Maria Coburn at 650-736-9551.